8 research outputs found

    Synthesis, Characterization, and in Vitro Evaluation of a New TSPO-Selective Bifunctional Chelate Ligand

    No full text
    The 18-kDa translocator protein (TSPO) is overexpressed in many types of cancers and is also abundant in activated microglial cells occurring in inflammatory neurodegenerative diseases. Thus, TSPO has become an extremely attractive subcellular target not only for imaging disease states overexpressing this protein, but also for a selective mitochondrial drug delivery. In this work we report the synthesis, the characterization, and the in vitro evaluation of a new TSPO-selective ligand, 2-(8-(2-(bis­(pyridin-2-yl)­methyl)­amino)­acetamido)-2-(4-chlorophenyl)<i>H</i>-imidazo­[1,2-<i>a</i>]­pyridin-3-yl)-<i>N</i>,<i>N</i>-dipropylacetamide (<b>CB256</b>), which fulfils the requirements for a bifunctional chelate approach. The goal was to provide a new TSPO ligand that could be used further to prepare coordination complexes of a metallo drug to be used in diagnosis and therapy. However, the ligand itself proved to be a potent tumor cell growth inhibitor and DNA double-strand breaker

    Reproducibility warning: The curious case of polyethylene glycol 6000 and spheroid cell culture - Fig 4

    No full text
    HT29 imaged by transmission light microscopy 96 h after plating in a 96 well plate treated for 1 h at 37°C with (A) PEG6000 from C.E., (B) PEG4000 (4000), (C) PEG6000 from S.A. (D) a mixture of 4000/S.A. 1/5 PRE diluted, (E) a mixture of 4000/S.A. 1/5, (F) mixture of 4000/S.A. 1/10, (G) PEG6000 from MERCK, (H) 4000/MERCK 1/5 pre-diluted, (J) 4000/MERCK 1/5, (K) 4000/MERCK 1/10, and (L) as control HT29 cells on an untreated surface. The scale bar in a) is valid for all images.</p
    corecore